Hypothermia: A Cold Weather Hazard
Authors: Ken Zafren, MD, FACEP, EMS Medical Director, State of Alaska; Staff Emergency Physician, Alaska Native Medical Center, Anchorage, AK, Clinical Assistant Professor and Staff Physician, Division of Emergency Medicine, Stanford University Medical Center, Stanford, CA; and Ingrid T. Lim, MD, Senior Emergency Medicine Resident Physician, Stanford/Kaiser Emergency Medicine Residency, Stanford, CA.
Peer Reviewer: Mary Jo Bowman, MD, FAAP, Associate Professor of Clinical Pediatrics, Ohio State University; Attending Physician and Pediatric Emergency Medicine Fellowship Director, Columbus Children’s Hospital, Columbus, OH.
Hypothermia causes 700-800 deaths per year in the United States alone.1 Half of those who die are older than 65 years.1 Many patients are hypothermic when they arrive in the emergency department (ED), but hypothermia may result from or be aggravated by failing to protect the patient from heat loss, administering room temperature or chilled IV fluids or blood, or using drugs that suppress shivering. Failing to recognize and treat hypothermia or allowing hypothermia to develop in a patient can lead to avoidable morbidity or mortality. Early recognition and aggressive management may prevent the life-threatening complications associated with this disease process.
This article will discuss the recognition and classification of hypothermia, how to prevent patients from becoming hypothermic, and options for treatment. The authors address some controversial areas, such as the best way to measure core temperature, the most effective methods for rewarming, and limitations to resuscitation. The Editor
Definition and Classification
Humans are homeothermic organisms, functioning best within a relatively narrow range of core temperatures, between 36°C to 37.5°C (97°F to 99°F). Hypothermia is a decline in the core temperature to less than 35°C (< 95°F).2 Accidental hypothermia, sometimes called primary hypothermia, results from exposure to cold environments without adequate protection. Secondary hypothermia is a complication of underlying disorders that decrease heat production, such as trauma, sepsis, and hypoendocrine states. Iatrogenic hypothermia can be caused by resuscitation with intravenous (IV) fluids at room temperature, by infusing chilled blood products, or by administering drugs that decrease shivering.
Accidental hypothermia is the reported cause of death in approximately 700 to 800 people per year in the United States.1 The elderly are particularly vulnerable to hypothermia, with 50% of all deaths occurring in patients older than 65 years.1
Other groups at risk include the homeless, chemically depen-dent, and mentally ill individuals, outdoor workers, trauma victims, and children. Although most cases occur during winter months, hypothermia can occur throughout the year, even in mild climates, and in individuals without outdoor exposure.2 Elderly and ill patients may become hypothermic, even in well-heated houses.
The ability to adapt to cold varies among individuals. Conditions that make some patients more susceptible to cold exposure include those associated with impaired heat production, increas-ed heat loss, or impaired thermoregulation. Endocrine disorders, hypoglycemia, malnutrition, and extremes of age are associated with decreased ability to increase heat production by shivering.3 Impaired thermoregulation occurs in both peripheral and central nervous system dysfunction. Individuals with peripheral neuropathies or spinal-cord injuries may be unaware of environmental conditions or may be unable to compensate by mechanisms such as vasoconstriction. Stroke, trauma, neoplasms, neurodegenerative disorders, and drugs can act centrally to decrease hypothalamic function. In addition, sepsis, pancreatitis, carcinomatosis, uremia, vascular insufficiency, and multisystem trauma also are associated with hypothermia.4 Numerous drugs, most commonly alcohol, impair temperature regulation. Alcohol causes peripheral vasodilation, leading to increased heat loss. Alcohol and other drugs also may interfere with the ability to make appropriate behavioral choices to seek shelter or wear protective clothing. Some medications (e.g., benzodiazepines, meperidine, and chlorpromazine) suppress shivering, and predispose to iatrogenic hypothermia.5,6
Body temperature is determined by the balance between heat production and heat loss. Increased heat production can be achieved by voluntary activity, by increased metabolism, by shivering, and is mediated by the thyroid and adrenal glands.
Heat is lost from the body in four ways: radiation, conduction, convection, and evaporation. Radiation is the direct exchange of heat (by radiant energy) between two objects separated in space. It depends upon surface area and the temperature difference between the objects. Conduction is heat transfer between two objects that are in direct contact. Convection is heat transfer by a moving fluid. This can occur when the body heats air or water surrounding its surface by conduction and movement (wind or water currents) and displaces the warmed fluid. Evaporation is heat lost by vaporizing a liquid. A large amount of heat can be lost from moist skin surfaces. The lungs also lose heat through evaporation (insensible respiratory loss).
The relative amount of heat lost by each mechanism depends upon conditions. Wet clothing, wet skin, and wind are factors that can dramatically increase heat loss. Wet clothing can increase the rate of heat loss by a factor of five, while immersion in water causes an increase of 25 to 30-fold.7 Children are more susceptible to hypothermia because they have a large body surface area relative to body mass.
Peripheral, especially cutaneous, vasoconstriction reduces heat loss. Shivering generates heat, increasing metabolism up to five times the baseline rate.8
However, humans are tropically adapted animals with limited ability to maintain core temperature in the face of environmental stresses encountered under more temperate conditions. The thermoneutral temperature of humans in still air is 28°C (82°F).7 Doubling the metabolic rate decreases the thermoneutral temperature only to 20°C (68°F). The ability to create a warm microclimate by the use of clothes and shelter is critical to human survival in temperate and polar climates.
Hypothermia affects multiple organ systems.
Cardiovascular. Initially, the patient’s heart rate, blood pressure, and cardiac output increase because of increased catecholamine production with peripheral vasoconstriction. After further cooling, there is an almost linear decrease in these parameters. At core temperatures below 28°C, bradycardia is a direct consequence of slowed conduction and decreased spontaneous depolarization of pacemaker cells.9 The myocardium becomes irritable, with a lower threshold for ventricular fibrillation.
Circulating blood volume markedly decreases to as little as one-third of normal, even in moderate hypothermia.10 As a consequence, even relatively modest infusions of fluids can have a significant effect on core temperature.
Central Nervous System (CNS). Hypothermia results in decreased cerebral blood flow, with decreased neuronal metabolism. This cerebroprotective response explains why the brain can endure ischemic injury in the setting of hypothermia. Clinically, there is a progressive decline in level of consciousness, manifesting as lack of fine motor coordination and clumsiness, followed by confusion, dysarthria, and impaired judgment and memory.
Renal. With mild hypothermia, peripheral vasoconstriction results in increased renal blood flow and a cold-induced diuresis, which depletes intravascular volume. As the temperature drops, the kidneys lose the ability to reabsorb water as the tubules become insensitive to antidiuretic hormone (ADH). In moderate hypothermia, the glomerular filtration rate declines as cardiac output falls and vascular tone increases. At lower temperatures, tubular capacity for hydrogen ion secretion is reduced, resulting in acidosis.11
Pulmonary. In mild hypothermia, initial tachypnea, is followed by a reduction in minute ventilation and reduced oxygen consumption.6 Bronchospasm and bronchorrhea develop. As the temperature drops into the range of moderate hypothermia, ciliary function is impaired, which can lead to aspiration and pneumonia. In severe hypothermia, progressive hypoventilation and apnea may develop. Pulmonary edema is a rare complication.
Oxygen Delivery. Falling temperatures cause a left shift of the oxyhemoglobin dissociation curve, resulting in impaired oxygen delivery and tissue hypoxia. However, this left shift is balanced by a rightward shift caused by acidosis that occurs with shivering and anaerobic metabolism. The problem of impaired oxygen delivery to the tissue is mitigated by the decreased oxygen demand at lower temperatures.
Hematologic. Hypothermia affects the erythrocytes, leukocytes, platelets, and clotting factors. The hematocrit increases by about 2% for every one degree Celsius decline in temperature.2
A normal hematocrit in a moderately or severely hypothermic patient should suggest anemia or blood loss. Leukocyte depletion can occur, along with impaired neutrophil migration and ineffective bacterial phagocytosis.12
Both decreased platelet numbers from sequestration in the liver and spleen and decreased platelet function occur with decreased production of thromboxane B2.13 Hypothermia can impair both the endothelial synthesis of prostacyclin (PGI2) and its inhibitory action on platelet aggregation, promoting platelet activation and thrombosis.11 Elevated cryofibrinogen levels raise the blood viscosity.
Cold also inhibits the enzymatic reactions of the coagulation cascade. The prothrombin (PT) and partial thromboplastin time (PTT) can be deceptively normal if measured at 37°C, but can be significantly increased if measured at lower temperatures. In-stead of replacing clotting factors, rewarming is the appropriate treatment for this type of coagulopathy.14 Disseminated intravascular coagulation can also occur.
Gastrointestinal. Below 34°C, intestinal motility decreases. Autopsy results can show shallow gastric ulcers known as Wischnevski’s ulcers.15 Hepatic impairment also may develop, likely because of decreased cardiac output. The reduced clearance of lactic acid also contributes to acidemia. Pancreatitis also frequently occurs in hypothermia. It is found at autopsy in 20-30% of cases.16 Although the mechanism is not well understood, it may be that thrombosis in the microcirculation causes ischemia and perilobular necrosis in the pancreas.11
Endocrine. Total body metabolism decreases with increasing hypothermia, as measured by a fall in oxygen consumption: 6% for every degree Celsius fall in temperature.17 The basal metabolic rate is reduced to 50% at a core temperature of 28°C.
Pharmacology. Drugs are generally ineffective below 30°C (86°F).6 Not only are the enzymatic systems on which they work affected, but protein binding increases. Because of decreased circulation to the skin, muscles, and gastrointestinal tract, only intravenous drugs are reliably absorbed. If they are given to a patient with a core temperature below 30°C (86°F), they are likely to remain inactive until the patent is rewarmed, at which point they become active when their effects may no longer be desirable.
Afterdrop. No discussion of hypothermia would be complete without mention of the dreaded afterdrop. This phenomenon refers to the continuing decrease in core temperature after removal from a cold environment, even when active rewarming is in progress. Although there was once controversy about the relative contribution of countercurrent heat exchange and increased flow of cool peripheral blood as vasoconstriction decreased, it is now clear that afterdrop is primarily a mass effect of continuing conduction of heat from the warmer core to the cooler peripheral tissues.
Several studies have measured peripheral blood flow during external rewarming and have noted minimal flow through skin and muscle while the afterdrop was occurring. Afterdrop also has been observed in fibrillating patients without any circulation.18 Afterdrop occurs because heat flows from an area of higher temperature to one of lower temperature. The temperature of the skin is usually 15-25°C (59-77°F), cooler than the temperature of the core of a hypothermic patient.18 No method of warming can transfer heat from the shell to the core against a temperature gradient. Until the temperature of the shell is raised to the temperature of the core, heat will continue to flow from the core to the periphery, and core temperature will fall despite application of external heat. Afterdrop cannot be prevented, but can be minimized. Even with optimal internal warming methods, afterdrop can be as much as 0.5° C (1° F).
Hypothermia is classified as mild from 32°C to 35°C (90-95°F), moderate from 28° to 32°C (82-90°F), and severe less than 28°C (< 82°F). (See Table 1.) The temperature ranges serve mainly as guidelines; there is a large variability in individual response to hypothermia. This classification system is of less use in multisystem trauma patients, in whom mortality rates approach 100% when core temperatures fall below 32°C (90°F).19
Mildly hypothermic patients are usually alert and shivering vigorously, but become progressively confused as they cool. Early features of hypothermia include impaired judgment and progressive loss of both fine and gross motor control. Initially respiratory rate, heart rate, and blood pressure are increased, but with further cooling, they are depressed.
Moderately hypothermic patients are confused and, as they cool, lose the ability to shiver. Although the average temperature at which shivering stops and consciousness is lost is said to be 30°C (86°F); some patients may be able to shiver and to carry on a conversation with a core temperature as low as 28°C (82°F).6 Respiratory rate, heart rate, and blood pressure continue to decrease in a linear fashion with further cooling.
Severely hypothermic patients are unconscious and may feel rigid. Vital signs may be difficult to obtain or may be absent. The presentation of hypothermia may be straightforward or easily overlooked as in an unconscious patient found indoors. The key to diagnosis is to measure the core temperature. Hypothermia frequently presents as a complication of another condition (e.g., trauma or intoxication with alcohol or other drugs). Iatrogenic hypothermia may occur in the ED or radiology suite secondary to failure to prevent heat loss, and therefore, may occur in normothermic patients after a period of time in the ED. Hypothermia also may occur in the settings of heat stroke cooling or emergency delivery.
Hypothermia is diagnosed by measuring the core temperature, which is the temperature of the internal organs, especially the heart. The diagnosis and treatment of hypothermia depend upon accurate measurement and tracking of core temperature. Esophageal temperatures provide the most accurate measure of core temperature with the probe placed by the same technique used for insertion of nasogastric or orogastric tubes. The technique is now standard in operating rooms, and, contrary to earlier beliefs, readings are not affected by inhalation of heated oxygen in intubated patients.
Epitympanic temperature is measured by a special probe in proximity to the tympanic membrane. Although not readily available in the United States, it provides a reasonable, noninvasive measure of core temperature through measurement of the temperature of blood in the carotid artery.20 This is a different device than the widely used infrared tympanic temperature devices, which are unreliable in hypothermia.
Rectal temperature is a poor index of core temperature, especially during rewarming. Rectal temperature changes lag behind changes in core temperature, with rectal temperatures still falling while the core temperature is increasing. Bladder catheter temperatures have the same limitations as rectal temperatures. Oral temperatures are affected by changes in ventilation and are useful only in excluding hypothermia. If using rectal or oral thermometers, remember that standard thermometers only read to a minimum of 34°C (93°F); special cold-reading thermometers should be used if esophageal or epitympanic probes are not available.
Although the diagnosis of hypothermia is based upon core body temperature, conditions other than cold exposure can cause hypothermia and should be considered as either the primary cause or as contributing factors.
Endocrine causes of hypothermia include hypothyroidism, adrenal and pituitary insufficiency, and hypoglycemia. Initial evaluation in hypothermic patients may include bedside glucose testing, empiric administration of steroids (use dexamethasone to preserve the ability to do later stimulation testing), and other laboratory tests as indicated.
Central nervous system problems that can cause or contribute to hypothermia include trauma, stroke, tumor, and other causes of hypothalamic dysfunction (e.g., Wernicke’s syndrome). Consider administration of thiamine (100 mg IV) and computed tomography (CT) imaging of the head.
Acute spinal cord transection causes vasodilation below the level of the lesion as well as paralysis. Patients who sustain a spinal cord injury in a cold environment are extremely susceptible to rapid cooling because of the inability to vasoconstrict peripheral vessels and the inability to shiver.
Alcohol and other drugs interfere with judgment and can promote sleep or induce coma. Exposure to carbon monoxide also can cause coma. Specific toxidromes may be present. The empiric use of naloxone (0.4 – 2 mg IV or more) may be diagnostic.
Myocardial infarction may be present in a hypothermia patient. Chest pain, dyspnea, lightheadedness, syncope, or other nonspecific symptoms may provide clues. The ECG and cardiac markers are the keys to diagnosis.
Peritonitis from abdominal injuries or other conditions (e.g., appendicitis) may be masked or may be simulated by a rigid abdomen in hypothermia. Other diagnostic methods (e.g., laboratory studies and CT imaging) may be necessary to make or exclude these diagnoses.
Hypothermia may be the consequence of infection, including meningitis, encephalitis, pneumonia, and sepsis. Especially in infants and immunocompromised patients, hypothermia may be a sign of overwhelming infection. Searching for the source of infection may include chest x-ray, urinalysis, lumbar puncture, and blood cultures.
Assessment and Initial Care in the Prehospital Phase. Safety of the rescuers is the first priority in prehospital care; they should take care not to become victims. The patient should be removed from the cold environment as soon as possible, but moderate and severely hypothermic patients should be removed very gently because the ventricular fibrillation threshold is lowered. Avoid unnecessary movement of the extremities to avoid flow of cooled blood from the periphery to the core. Gently remove wet clothing by cutting it off. Cover the patient, including the head and neck, to avoid heat loss. Heat the inside of ambulances to 28°C (82°F).
Patients who have an altered level of consciousness, who are not shivering vigorously or at all, and who have depressed vital signs are likely to be hypothermic. Measure the core temperature as soon as possible, preferably with an esophageal probe thermometer. Administer heated humidified oxygen, and intubate patients whose depressed level of consciousness presents an aspiration risk. If possible, ventilate moderate or severely hypothermic patients with heated humidified oxygen, which may decrease the fibrillation threshold. Because metabolism is decreased, decrease the ventilatory rate, to about one-half the normal rate, to avoid hyperventilating the patient.
Most patients who are hypothermic are volume depleted and require intravenous fluids. Fluids should be administered to replace estimated deficits rather than for rewarming, and heated when possible to 40-42°C (104-108°F). Give fluid as boluses and titrate to effect, rather than giving continuous infusions.
Hypothermic patients without vital signs or other signs of life present a great challenge. Patients suffering from severe hypo-thermia have been resuscitated with full neurologic recovery. Dependent lividity, apparent rigor mortis, and fixed, dilated pupils are not contraindications to resuscitation. At 23°C (73°F) all re-flexes are absent, including corneal and oculocephalic reflexes. At 19°C (66°F) electroencephalographic (EEG) activity is absent.6
However, in contrast to the adage that “nobody is dead until they are warm and dead,” some people are cold and dead. Unfortunately, patients who have been totally submerged in cold water for significantly more than 1 hour, have a core temperature below 10°C (50°F), have obvious lethal injuries (e.g., decapitation, total exsanguination, or tissue decomposition), are frozen (e.g, ice formation in the airway), or have a chest wall so stiff that compressions are impossible will not survive. The lowest recorded temperature for a survivor of accidental hypothermia is 13.7°C.21 Studies have demonstrated that most survivals after prolonged submersion involved water colder than 5°C (41°F).22 Submersion for up to 88 minutes in water or cardiopulmonary resuscitation (CPR) for many hours is still compatible with intact survival.23-25
Field treatment may be limited by an inability to perform cardiac monitoring. Patients may have vital signs and a perfusing cardiac rhythm, which are undetectable without monitoring. Because hypothermia decreases the metabolic requirements of organs, especially the brain, these patients may be stable – in a so-called metabolic ice box. Starting chest compressions could precipitate ventricular tachycardia (VT) or ventricular fibrillation (VF). An automated electronic defibrillator may be used for initial evaluation of the cardiac rhythm. The signal to shock means that the patient is in VT or VF. Palpation of a weak, bradycardic pulse in a cold, stiff, hypothermic patient, may be difficult. Treat any organized cardiac rhythm as a sign of life, and do not start chest compressions. It is not worth the risk of converting a perfusing rhythm to VT or VF with chest compressions, although the evidence for this is only circumstantial.26,27 Chest compressions typically are more difficult and require more force. The cardiac output achieved during CPR will be only 50% of that achieved during normothermic CPR.18 Defibrillation should be attempted at standard energy settings (three attempts) for VF or pulseless VT, but realize that attempts likely will be unsuccessful at core temperatures less than 30-32°C (86-90°F). Defer further attempts until the patient has been rewarmed above 32°C (90°F) according to Advanced Cardiac Life Support (ACLS) guidelines. Do not give drugs, including anti-arrhythmics. Drugs are generally ineffective below 32°C (90°F). However, give naloxone (0.4 – 2 mg IV or more), thiamine (100 mg IV) and glucose (D50W-1 ampoule) empirically.
More complete guidelines for prehospital care, including care involving prolonged transport times and field rewarming can be found in the State of Alaska Cold Injuries Guidelines.28
Emergency Department Care
Once the patient arrives in the ED, carefully re-evaluate airway, breathing, and circulation and continue to avoid movement or manipulation of the patient that might precipitate VF. Because cold skin is injured easily, avoid direct application of hot objects or excessive pressure (e.g., uninsulated hot water bottles or BP cuffs). Continue forced air rewarming, and cover the patient’s head and neck with warm blankets.
Ventilation often is compromised by associated chest rigidity and decreased diaphragmatic movement. Consider fiberoptic intubation if there is severe jaw rigidity. The oral route is preferred because of risk of coagulopathic bleeding with nasotracheal intubation. However, muscular rigidity may complicate orotracheal intubation. Do not use neuromuscular blockers, which are not effective at temperatures below 30°C (86°F).29 Intubation does not appear to induce VF.30 Patients may require frequent tracheal suctioning in the setting of cold-induced bronchorrhea. Pulse oximetry is unlikely to be accurate or even possible in the setting of hypothermia and poor perfusion.
Circulatory status is often difficult to assess in hypothermic patients due to the extreme peripheral vasoconstriction. A Doppler ultrasound may be necessary to detect a pulse. Peripheral venous access is preferred but may be difficult. Pulmonary artery catheters and central venous catheters in the subclavian or jugular veins should be avoided because of the potential for causing VT or VF. If initial defibrillation was unsuccessful, resume CPR, begin rewarming, and attempt defibrillation again only when the core temperature reaches 32°C (90°F). Most hypothermia-induced dysrhythmias convert spontaneously with rewarming. Atrial fibrillation is common but is usually rate-controlled because of slowed ventricular response and resolves spontaneously with rewarming. Antiarrhythmic and vasoactive drugs in the moderate to severely hypothermic patient are usually ineffective at core temperatures less than 30°C,31 and once the core temperature is above 30°C (86°F), only the lowest effective dose should be used because of potential toxicity with altered metabolism. Bretylium tosylate has been effective in animal studies.32,33 The optimal dose and infusion rate of bretylium and other vasoactive drugs are unknown and indications are unclear for patients with hypothermia.
An almost universal requirement in hypothermia is aggressive volume resuscitation. The standard fluid is 5% dextrose in normal saline (D5NS). Lactated Ringer’s should not be used because of decreased ability of the liver to metabolize lactate. Intravenous fluids should be heated to 40-42°C (104-108°F). If a commercial fluid warmer is not available, heat intravenous fluids in a microwave oven and remember to shake the solution after heating to eliminate hot spots. Because the circulating blood volume is decreased by as much as two-thirds in moderate hypothermia,10 this fluid can provide significant rewarming. In cases of moderate or severe hypothermia, place a nasogastric or orogastric tube to relieve gastric distention and decrease the risk of aspiration. A urinary catheter is useful in monitoring urine output and volume resuscitation efforts.
Do not use medications prior to rewarming. Medications, if administered in mildly hypothermic patients, should be given only intravenously; oral, rectal, and intramuscular routes are unreliable. Phenothiazines, meperidine (Demerol), buspirone, and other drugs reduce or abolish the ability to shiver.
Once initial stabilization has been accomplished, a thorough secondary survey should be performed to identify conditions that may have led to or resulted from hypothermia. Patients who are mildly hypothermic should be alert; if they have an altered level of consciousness, search for a cause other than hypothermia.
Vital signs may be helpful for identifying other problems; respiratory rates that are too fast or too slow for a given core temperature suggest metabolic acidosis or a central nervous system lesion; heart rate should be about 50% of normal at a core temperature of 28°C (86°F),6 if faster than expected, look for other causes (e.g., hypovolemia, hypoglycemia, or drug ingestions).
Electrocardiogram (ECG). Impaired cardiac electrical activity can be seen on ECG tracings. Repolarization abnormalities, which appear as distinctive Osborn or J waves, are most prominent in the precordial leads V2-V5 and occur in one-third of hypothermic patients, at temperatures below 32°C (90°F).6 Although the amplitude of the J wave correlates with the degree of hypothermia, J waves are not pathognomonic of hypothermia and may also be seen with subarachnoid hemorrhage, other cerebral injuries, and with myocardial ischemia. Other ECG changes include widened QRS complexes, with ST elevation or depression, and T-wave inversions. QT prolongation and AV block may develop days after normal temperature has been restored.11
Arterial Blood Gases. Arterial blood gas measurement may be used to monitor patients. Uncorrected blood gas samples are heated routinely to 37°C prior to analysis. Corrected values, derived from factors applied to account for temperature effects on gas pressure solubility and hemoglobin dissociation curves, should not be used because there will be a spurious increase in pH levels and a decrease in carbon dioxide tension. The arterial blood gas measurement commonly shows a combined metabolic acidosis (decreased tissue perfusion with accumulation of lactate) and respiratory acidosis (decreased respiratory effort and CNS depression).
Hematologic Testing. Because hypothermia has an associated expected rise in hematocrit, a normal or low value suggests acute hemorrhage or preexisting anemia. White blood cell and platelet counts are artificially lowered by sequestration. Expect low counts to normalize with rewarming.
Electrolytes. Monitor serum electrolyte levels during rewarming. Potassium levels do not vary with core temperature, but hypothermia increases the toxicity of potassium. Both hypokalemia and hyperkalemia may complicate the course of resuscitation. Hyperkalemia is a marker of acidosis and cell death. In hypothermic patients who have underlying trauma or asphyxia, potassium levels greater than 10 mEq/L predict failure of attempted resuscitation.34 The ECG is not helpful because potassium-induced ECG changes are less evident in hypothermia.
Glucose. Blood glucose levels may be elevated in mild hypothermia because of catecholamine-induced glycogenolysis and in moderate to severe hypothermia because endogenous insulin has decreased activity below 30°C (86°F). Subacute and chronic hypothermia cause glycogen depletion with subsequent hypoglycemia. Hypoglycemia is a common cause of hypothermia in the hospitalized patient.29
Coagulation Studies. Hypothermia causes coagulopathy, but the interpretation of the coagulation profile is difficult. PT and PTT may be deceptively normal unless measured at the patient’s temperature instead of being warmed to 37°C. Instead of replacing clotting factors, rewarming is the appropriate treatment for this type of coagulopathy. If rewarming is successful, correct any residual coagulopathy. Disseminated intravascular coagulation (DIC) may occur after rewarming.
Amylase. Hyperamylasemia can be a result of preexisting pancreatitis or of pancreatitis induced by hypothermia. It correlates with the severity of hypothermia and mortality.29
Other Tests. If the cause of hypothermia is not known, consider adding thyroid function tests, toxicology screens, ethanol level and serum amylase tests, as well as urinalysis and cultures to rule out infection.
Radiologic Testing. The indications for x-rays are similar to those for normothermic patients.
The choice of rewarming techniques depends upon the severity of hypothermia, the hemodynamic status of the patient, institutional and physician preference, and the availability of specialized personnel and equipment. (See Table 2.)
Passive External Rewarming. Passive external rewarming (PER) requires the patient to produce heat spontaneously, making it useful only for the mildest cases of hypothermia. The patient should have all wet clothing removed, be placed in a warm, dry environment and covered (remember to cover the head and neck) with an insulating material to prevent further heat loss. Rewarming rates with PER in mild hypothermia vary between 0.5-2.0°C per hour.2
Active Rewarming. Provide active rewarming the addition of exogenous heat for all patients who cannot generate sufficient heat for PER. Indications for active rewarming include cardiovascular instability, poikilothermia (core temperature < 32°C [< 90°F]), inadequate rewarming with other methods, endocrinologic insufficiency, and traumatic peripheral vasodilation due to spinal cord injury.29
Active External Rewarming. Active external rewarming (AER) involves transfer of exogenous heat to the patient via the skin. These methods, which include heating blankets, forced heated air systems, or heating lamps, are widely used because they are familiar, inexpensive, and readily available. They quickly rewarm hypothermic patients and often are all that is necessary in mild or even moderate hypothermia.
Theoretically, if the periphery is rewarmed before the core, cold, acidemic blood returns to the heart. In practice, this is not a problem with forced-air rewarming.35 A number of devices in which heated air is blown into a semiclosed cover over the patient’s trunk and extremities are available and forced air rewarms more quickly than blankets alone (2.4°C/h compared with 1.4°C/h).36,37 Newer devices are small enough to be used in ground or air ambulances. A special portable rigid forced air cover (PORIFAC) has been developed for prehospital use.38
Another active external rewarming technique makes use of arteriovenous anastamoses (AVA). These anastamoses, which are found in the forearm and calf vessels, normally close during vasoconstriction in hypothermia. In AVA rewarming, the anastamoses are opened by heat or by negative pressure and heat is applied. In one version, the mildly or moderately hypothermic patient sits on a chair with arms to the elbows and legs to the knees immersed in 44-45° C (111-113°F) water.39 In a second version, one arm is placed in a negative pressure sleeve, and hot water is circulated in tubing inside the sleeve. Early research gave promising results,40 but subsequent studies have failed to demonstrate its usefulness,41 and at least one subject in an unpublished study sustained a burn.42
Active Core Rewarming. Active core rewarming (ACR) techniques are the most effective and rapid methods of raising the core temperature; numerous alternatives are available and range from minimally invasive to extracorporeal warming.6,42
Humidified oxygen heated to 40-45°C (104-113°F) should be used in all hypothermia resuscitations. Theoretically, airway rewarming has little influence on outcome; it can cause an elevation in core temperature of no more than 1-1.5°C (2-3°F) per hour.30 However, the small contribution to temperature rise is synergistic with other modalities. Inhalation therapy helps to maintain core temperature by preventing heat loss during expiration, which may be equivalent to approximately 10% of metabolic heat production. It may warm the hypothalamus and reverse the cold-induced depression of respiratory centers, improving the level of consciousness.
A variety of body cavities can be heated by irrigation with warmed fluids. Therapeutic peritoneal lavage seems to be the most effective method. To use the single catheter technique, infuse 2 L of dialysate or other isotonic fluid (e.g., normal saline) at 44°C (111°F) every 20-30 minutes, and then suction as much as possible before the next cycle. Alternatively, place two catheters through the midline into the right and left abdominal gutters and use them as afferent and efferent exchange lines to exchange up to 6 L/h.43 Advantages of peritoneal lavage include hepatic rewarming, renal support when dialysate is used, and the ability to continue cardiopulmonary resuscitation. Rewarming rates average 1-3 degrees/hr.29
Although less effective than peritoneal lavage, closed thoracic lavage may be useful if the patient has another indication for tube thoracostomy (e.g., pneumothorax or hemothorax). Two large thoracostomy tubes should be placed: one in the anterior second or third intercostal space in the midclavicular line and a second tube in the posterior axillary line in the fifth or sixth intercostal space. Infuse sterile normal saline heated to 40-42°C (104-108°F) through the anterior tube and allow it to drain passively into the posterior tube. The left hemithorax is preferred because it exposes the bulk of the myocardium and the great vessels to rewarming. Although rarely employed, mediastinal irrigation and myocardial lavage could be considered in patients who have severe hypothermia and no spontaneous perfusion, but require expertise in thoracotomy.44
Irrigation of the stomach, bladder, or colon is not very effective, because the surface area available for heat transfer is minimal. Gastric lavage has the additional risk of aspiration and cannot be continued during chest compressions.
Extracorporeal Methods. Extracorporeal methods include hemodialysis, arteriovenous rewarming, venovenous rewarming, and cardiopulmonary bypass (CPB). Hemodialysis utilizes a two-way flow catheter with percutaneous cannulation of a single vessel. The femoral vein is preferable because of the risk of myocardial irritation with the guide wire if other routes are used. Consider this technique in hemodynamically stable patients, with associated severe renal dysfunction or intoxication with dialyzable substances. Newer techniques of arteriovenous and venovenous rewarming, utilize counter-current fluid rewarming. Arteriovenous techniques depend upon the patient’s blood pressure, which must be at least 60 mm Hg systolic.45 Venovenous techniques require a roller pump and are described in more detail in the literature.6,29
Cardiopulmonary bypass (CPB) is the most invasive and labor-intensive technique for rewarming. It utilizes the standard femoral artery-femoral vein access. It has the advantages of complete hemodynamic support during rewarming, and rapid rise in temperature, as quickly as 1-2°C (2-4°F) every 3 to 5 minutes. CPB is the modality of choice in cardiopulmonary arrest. It also is indicated in patients with 1) cardiac arrest or hemodynamic instability with a core temperature of less than 32°C (90°F); 2) no response to less invasive techniques; 3) completely frozen extremities; and 4) rhabdomyolysis with severe hyperkalemia.9 Disadvantages include the need for considerable set-up time, trained personnel, and access to appropriate resources. Historically, CPB has required systemic anticoagulation, which is contraindicated in patients with known traumatic injuries, but the use of heparin-bonded tubing allows CPB use even in the setting of trauma.44,47 Long-term outcome of patients who have severe hypothermia treated with CPB has been favorable.48
New developments in hypothermia treatment continue to emerge. In animal studies, a technique under investigation is administration of intravenous fluids heated to 65°F (149°F). Rewarming rates doubled to 2.9 to 3.7°C (37.22 to 38.66°F) per hour without increasing apparent complications.49,50 However, this technique is likely to cause skin damage in hypothermic human patients and although animal studies are promising, further investigation is needed.51
Indwelling venous heat-exchange catheters, placed in the femoral vein, have been used to produce mild hypothermia in studies of neuroprotective effects after stroke or cardiac arrest.52,53 Their use in rewarming has not been extensively studied.54 Because of the restriction of circulating blood volume in hypothermia,10 they may prove to be quite effective, while being minimally invasive.
Discharge is possible in most otherwise healthy patients with mild hypothermia who have been rewarmed, unless they have associated injuries or conditions that necessitate admission. Admit all patients with moderate or severe hypothermia. Patients who require resources not available at the facility may benefit from transfer.
Severe or prolonged hypothermia may cause noncardiogenic pulmonary edema, gastric submucosal hemorrhage, pancreatic necrosis, cerebrovascular accidents, and myocardial infarction. Pneumonia is very common secondary to loss of protective cough reflexes, cold-induced bronchorrhea, and direct injury to lung tissue. It is the leading cause of death among patients who survive rewarming.37
Mortality rates among hypothermic patients are highly variable and attempts to identify prognostic factors have had limited success. Few studies are published, many of which are retrospective chart reviews in selected patient populations that have produced variable results, some of which contradict each other.
Danzl and colleagues conducted a prospective multicenter study in North America involving 428 patients (mostly adults) with no standardized rewarming methods. The overall mortality rate was 17%. They delineated five risk factors for death within 24 hours: blood urea nitrogen greater than 100, systolic blood pressure less than 70 mm Hg, prehospital CPR, tracheal intubation, and nasogastric tube placement. Factors found not to correlate with survival included immersion, major trauma, comorbid illness, age, and sex.30
A small retrospective French study of 47 ICU patients during a 19-year period with a mortality rate of 38% found the following factors to be associated with a poor prognosis: delay after the incident, a slow rewarming rate, and the need for vasopressors. In this highly selected group of very sick patients, baseline temperature did not correlate with prognosis.55
A small Austrian study of 55 patients, all with core temperatures less than 30°C (86°F), used different methods of rewarming based on the hemodynamic status of the patients.56 Survival was 100% in the group with stable hemodynamics who were rewarmed with airway rewarming, warm fluids, and insulation; 72% in the group with unstable hemodynamics who were rewarmed by peritoneal dialysis; and 13% in the group with cardiac arrest who were rewarmed by extracorporeal circulation. The prognosis was excellent in patients without hypoxia or serious underlying disease.
A much larger Swiss study of 234 patients during an eight-year period found that the most important negative survival factors included asphyxia, slow rate of cooling, asystole on arrival, elevated serum potassium level, and increased age.57 Temperature on arrival was not correlated with survival.
Although hypothermia is a favorable prognostic factor after hypoxic events, a fact recognized in pediatric submersion, prolonged submersion with resultant severe hypothermia still carries a grim prognosis.24,58-60
Therapeutic Hypothermia. The cerebroprotective effects of hypothermia have potential benefits in patients who have had nontraumatic hypoxic insults (e.g., cardiac arrest and stroke).61,62 This evolving field is beyond the scope of this article, but is relevant to the use of therapeutic hypothermia in trauma patients, which is reviewed in the next section.
Hypothermia in Trauma Patients
Hypothermia in trauma has the potential to increase morbidity and mortality through its effects on coagulation and the heart and has been identified as one element in a lethal triad of hypothermia, acidosis, and coagulopathy.64 Recognition of the lethal triad has led to the introduction of abbreviated laparotomy (damage control surgery) in some trauma patients.64,65 However, hypothermia has potential benefits in trauma as well, by cerebral protective effects in traumatic brain injury. To date, studies have had mixed results.66-69 Hypothermia also has the potential to permit otherwise impossible salvage surgery,64 and to allow suspended animation during circulatory arrest. A number of laboratory studies have shown cerebral protection using therapeutic hypothermia in dogs who have been exsanguinated or have had delayed resuscitation from cardiac arrest.69-74 In addition, the effect of hypothermia in decreasing immunologic response may be beneficial in trauma.75
Although ATLS stresses measures to prevent and treat hypothermia in trauma patients, it is not clear whether hypothermia itself causes increased mortality or whether it is associated with metabolic derangements caused by severe trauma. A retrospective review of 173 trauma patients found no increase in mortality in hypothermic trauma patients when patients were stratified by injury severity.76 An older, retrospective study of 71 patients characterized hypothermia as an “ominous predictor of survival.”19 The mortality rate was 40% when the core temperature was less than 34°C (93°F), 69% when temperature was less than 33°C (91°F), and 100% when the temperature was less than 32°C (90°F). However, this study looked only at severely injured patients (i.e., those with a Injury Severity Score > 25), did not pursue aggressive rewarming, and all patients underwent surgery for definitive treatment. The authors were careful to stress that their study did not address the issue of whether the hypothermia itself or the severity of the injury that caused the hypothermia was responsible for the increased mortality. A more recent study of 395 trauma patients in an intensive care setting found a few survivors with core temperatures less than 32°C (90°F).77
Hypothermia is a potentially life-threatening problem in the ED. Recognition should be straightforward, but diagnosis of associated conditions and management are fraught with difficulties. Mildly hypothermic patients without comorbidities can rewarm themselves with minimal help. Most other hypothermic patients require active rewarming, which can be a difficult process. Early aggressive management may prevent life-threatening complications and avoid the morbidity and mortality associated with hypothermia.
1. Centers for Disease Control and Prevention (CDC). Hypothermia-related deathsUnited States, 2003-2004. MMWR Morb Mortal Wkly Rep 2005; 54:173-175.
2. Danzl DF, Pozos RS. Accidental hypothermia. NEJM 1994;331: 1756-1760.
3. Danzl DF. Hypothermia. Semin Respir Crit Care Med 2002;23:57-68.
4. Kempainen RR, Brunette DD. The evaluation and management of accidental hypothermia. Respir Care 2004;49:192-205.
5. Giebrescht GG, Gohen MS, Johnston CE, et al. Inhibition of shivering increases core temperature afterdrop and attenuates rewarming in hypothermic humans. J Appl Physiol 1997;83:1630-1634.
6. Danzl DF. Accidental hypothermia. In: Auerbach PS, ed. Wilderness Medicine. 4th ed. St. Louis: Mosby; 2001:135-177.
7. McCauley RL, Smith DJ, RObson MC, et al. Frostbite. In: Auerbach PS, ed. Wilderness Medicine 4th ed. St. Louis: Mosby 2001:178-196.
8. Blum FC, Veach J. Hypothermia and frostbite. In: Howell JM, ed. Emergency Medicine. Philadelphia:WB Saunders; 1998:1574-1584.
9. Ulrich AS, Rathlev NK. Hypothermia and localized cold injuries. Emerg Med Clin North Am 2004;22:281-298.
10. Vanggaard L, Eyolfson D, Xu X, et al. Immersion of distal arms and legs in warm water [AVA rewarming] effectively rewarms mildly hypothermic humans. Aviat Space Env Med 1999;70:1081-1088.
11. Mallet ML. Pathophysiology of accidental hypothermia. QJM 2002;95: 775-785.
12. Shenaq SA, Yawn DH, Saleem A, et al. Effect of profound hypothermia on leukocytes and platelets. Ann Clin Lab Sci 1986;79:528-531.
13. Michelson AD, MacGregor H, Barnard MR, et al. Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro. Thromb Haemost 1994;71:633-640.
14. Reed RL, Johnson TD, Hudson JD, et al. The disparity between hypothermic coagulopathy and clotting studies. J Trauma 1992; 33:465-470.
15. Birchmeyer MS, Mitchell EK. Wischnewski revisited: The diagnostic value of gastric mucosal ulcers in hypothermic deaths. Am J Forensic Med Pathol 1989;10:28-30.
16. Maclean D, Mirson J, Griffiths PD. Acute pancreatitis and diabetic ketoacidosis in accidental hypothermia and hypothermic myxoedema. BMJ 1973;4:757-761.
17. Wong KC. Physiology and pharmacology of hypothermia. West J Med 1983;138:227-232.
18. Reed RL, Gentilello LM. Temperature-Associated Injuries and Syndromes. In: Moore EE, Feliciano DV, Mattox KL, eds. Trauma. 5th ed. New York: McGraw-Hill; 2004:1099-1108.
19. Jurkovich GJ, Greiser WB, Luterman A, et al. Hypothermia in trauma victims: an ominous predictor of survival. J Trauma 1987;27:1019-1024.
20. Corneli HM. Hot topics in cold medicine: Controversies in accidental hypothermia. Clin Ped Emerg Med 2001;2:179-191.
21. Gilbert M, Busund R, Skagseth A, et al. Resuscitation from accidental hypothermia of 13.7 degrees C with circulatory arrest. Lancet 2000;355: 375-376.
22. Orlowski JP. Drowning, near-drwoning, and ice-water drowning. JAMA 1988;260:390-391.
23. Bolte RG, Black PG, Bowers RS, et al. The use of extracorporeal rewarming in a child submerged for 66 minutes. JAMA 1988;60: 377-379.
24. Young R, Zalneraitis EL, Dooling EC. Neurologic outcomes in cold water drowning. JAMA 1980;244:1233-1235.
25. Schmidt U, Fritz KW, Kasperczyk W, et al. Successful resucitation of a child with severe hypothermia after cardiac arrest of 88 minutes. Prehosp Disaster Med 1995;10:60-62.
26. Steinman AM. Cardiopulmonary resuscitation and hypothermia. Circulation 1986;74:IV29-IV32.
27. Zell SC, Kurtz KJ. Severe exposure hypothermia: A resuscitation protocol. Ann Emerg Med 1985;15:390-396.
28. Section of Community Health and EMS. Cold Injuries Guidelines: Alaska Multi-level 2003 Version. Available at: http://www.chems.alaska.gov/EMS/documents/AK_Cold_Inj_2003.pdf. Accessed:Feb. 13, 2005.
29. Hanania NA, Zimmerman JL. Accidental Hypothermia. Crit Care Clin 1999;15:235-249.
30. Danzl DF, Pozos RS, Auerbach PS, et al. Multicenter hypothermia survey. Ann Emerg Med 1987;16:1042-1055.
31. Schwarz B, Mair P, Wagner-Berger K, et al. Neither vasopressin nor amiodarone improve CPR outcome in an animal model of hypothermic cardiac arrest. Acta Anesthesiol Scand 2003;47:1114-1118.
32. Orts A, Alcaraz C, Delaney KA, et al. Bretylium tosylate and electrically induced cardiac arrhythmias during hypothermia in dogs. Am J Emerg Med 1992;10:311-316.
33. Murphy K, Nowak RM, Tomlanovich MC. Use of bretylium tosylate as prophylaxis and treatment in hypothermic ventricular fibrillation in the canine model. Ann Emerg Med 1986;15:1160-1166.
34. Mair P, Kornberger E, Furtwaengler W, et al. Prognostic markers in patients with severe accidental hypothermia and cardiocirculatory arrest. Resuscitation 1994;27:47-54.
35. Kornberger E, Schwartz B, Lindner KH, et al. Forced air surface rewarming in patients with severe accidental hypothermia. Resuscitation 1999;41: 105-111.
36. Koller R, Schnider TW, Neidhart P. Deep accidental hypothermia and cardiac arrest: Rewarming with forced air. Acta Anaesthesiol Scand 1997; 41:1359-1364.
37. Thompson DA, Anderson N. Successful resuscitation of a severely hypothermic neonate. Ann Emerg Med 1994;23:1390-1393.
38. Giesbrecht GG, Pachu P, Xu X. Design and evaluation of a portable forced-air warming cover for prehospital transport of cold paitents. Aviat Space Env Med 1998;69:1200-1203.
39. Vanggaard L, Gjerloff CC. A new simple technique of rewarming in hypothermia. Int Rev, Army Navy Air Force Med Services 1979;52: 427-430.
40. Grahn D, Brock-Utne JG, Watenpaugh DE, et al. Recovery from mild hypothermia can be accelerated by mechanically distending blood vessels in one hand. J Appl Physiol 1998;85:1643-1648.
41. Smith CE, Parand A, Pinchak AC, et al. The failure of negative pressure rewarming (Thermostat TM) to accelerate recovery from mild hypothermia in postoperative surgical patients. Anesth Analg 1999; 89:1541-1545.
42. Giesbrecht GG. Cold stress, near drowning and accidental hypothermia: a review. Aviat Space Environ Med 2000;71:733-752.
43. Johnson L. Hypothermia. Lippincott Williams & Wilkins. Available at: http://online.statref.com/document.aspx?fxid=35&docid=1821. Accessed: Oct 26, 2004.
44. Brunette DD, McVaney K. Hypothermic cardiac arrest: An 11 year review of ED management and outcome. Am J Emerg Med 2000:1 8:418-422.
45. Gentilello LM, Cobean RA, Offner PJ, et al. Continuous arteriovenous rewarming: rapid reversal of hypothermia in critically ill patients. J Trauma 1992;32:316-327.
46. Perchinsky MJ. Extracorporeal cardiopulmonary life support with heparin-bonded circuitry in the resuscitation of massively injured trauma patients. Am J Surg 1995;169:488-491.
47. Kirkpatrick AW, Garraway N, Brown DR, et al. Use of a centrifugal vortex blood pump and heparin-bonded circuit for extracorporeal rewarming of severe hypothermia in acutely injured and coagulopathic patients. J Trauma 2003;55:407-412.
48. Walpoth BH, Walpoth-Aslan BN, Mattle HP, et al. Outcome of survivors of accidental deep hypothermia and circulatory arrest treated with extracorporeal blood rewarming. NEJM 1997;337:1500-1505.
49. Sheaff CM, Fildes JJ, Keogh P. Safety of 65°C intravenous fluid for the treatment of hypothermia. Am J Surg 1996;172:52-55.
50. Fildes J, Sheaff C, Barrett J. Very hot intravenous fluid in the treatment of hypothermia. J Trauma 1993;35(5):683-686.
51. Giesbrecht GG, Bristow GK. Recent advances in hypothermia research. Ann N Y Acad Sci 1997;813:663-675.
52. Georgiadis D, Schwarz S, Kollmar R, et al. Endovascular cooling for moderate hypothermia in patients with acute stroke. Stroke 2001;32:2550-2553.
53. Keller E, Imhof HG, Gasser A, et al. Endovascular cooling with heat exchange catheters: a new method to induce and maintain hypothermia. Intensive Care Med 2003;29:939-943.
54. Inderbitzen B, Yon S, Lasheras J, et al. Safety and performance of a novel intravascular catheter for induction and reversal of hypothermia in a porcine model. Neurosurgery 2002;50:364-370.
55. Vassal T, Benoit-Gonin B, Carrat F, et al. Severe accidental hypothermia treated in an ICU: prognosis and outcome. Chest 2001;120:1998-2003.
56. Kornberger E, Mair P. Important aspects in the treatment of severe accidental hypothermia: the Innsbruck experience. J Neurosurg Anesthesiology 1996;8:83-87.
57. Locher T, Walpoth B, Pfluger D, et al. Accidental hypothermia in Switzerland (1980-1987) - causes and prognostic factors. Schweiz. Med Wschr 1991;121:1020-1028.
58. Quan L, Kindler D. Pediatric submersions: Prehospital predictors of outcome. Pediatrics 1992;90:909-913.
59. Wollenek G, Honarwar N, Golej J, et al. Cold water submersion and cardiac arrest in treatment of severe hypothermia with cardiopulmonary bypass. Resuscitation 2002;52:255-263.
60. Farstad M, Andersen KS, Koller ME, et al. Rewarming from accidental hypothermia by extracorporeal circulation: A retrospective study. Eur J Cardiothorac Surg 2001;20:58-64.
61. The Hypothermia After Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N EJM 2002;346:549-556.
62. Holzer M, Bernard SA, Hachimi-Idrissi S,et al. Hypothermia for neuroprotection after cardiac arrest: systematic review and individual patient data meta-analysis. Crit Care Med 2005;33:414-418.
63. Kirkpatrick AW, Chun R, Brown R, et al. Hypothermia and the trauma patient. Can J Surg 1999;42:333-343.
64. Mattox KL. Introduction, background and future projections of surgery. Surg Clin North Amer 1997;77:753-759.
65. Eddy V, Morris JA, Cullinane DC. Hypothermia, coagulopathy and acidosis. Surg Clin North Amer 2000;80:845-854.
66. Marion DW, Penrod LE, Kelsey SF, et al. Treatment of traumatic brain injury with moderate hypothermia. NEJM 1997;335:540-546.
67. Clifton GL, Miller ER, Choi SC, et al. Lack of effect of induction of hypothermia after acute brain injury. NEJM 2001;344:556-563.
68. Qiu WS, Liu WG, Shen H, et al. Therapeutic effect of mild hypothermia on severe traumatic head injury. Chin J Traumatol 2005;8:27-32.
69. Nozari A, Safar P, Wu X, et al. Suspended animation can allow survival without brain damage after traumatic exsanguination cardiac arrest of 60 minutes in dogs. J Trauma 2004;57:1266-1275.
70. Behringer W, Safar P, Wu X, et al. Survival without brain damage after clinical death of 60-120 mins in dogs using suspended animation by profound hypothermia. Crit Care Med 2003;31:1523-1531.
71. Capone A, Safar P, Radovsky A, et al. Complete recovery after normothermic hemorrhagic shock and profound hypothermic circulatory arrest of 60 minutes in dogs. J Trauma 1996;40:338-395.
72. Behringer W, Prueckner S, Kentner R, et al. Rapid hypothermic aortic flush can achieve survival without brain damage after 30 minutes cardiac arrest in dogs. Anesthesiology 2000;93:1491-1499.
73. Safar P, Tisherman SA, Behringer W, et al. Suspended animation for delayed resuscitation from prolonged cardiac arrest that is unresuscitable by standard cardiopulmonary-cerebral resuscitation. Crit Care Med 2000;28:N214-228.
74. Tisherman SA, Safar P, Radovsky A, et al. Profound hypothermia (< 10°C) compared with deep hypothermia (15°C) improves neurologic outcome in dogs after two hours’ circulatory arrest induced to enable resuscitative surgery. J Trauma 1991;31:1051-1061.
75. Hildebrand F, Giannoudis PV, van Griensven M. Pathophysiologic changes and effects of hypothermia on outcome in elective surgery and trauma patients. Am J Surg 2004;187:363-371.
76. Steinemann S, Shackford SR, Davis JW. Implications of admission hypothermia in trauma patients. J Trauma 1990;30:2000-2002.
77. Rutherford EJ, Fusco MA, Nunn CR. Hypothermia in critically ill trauma patients. Injury 1998;29:605-608.